Anastasia Velentza

Anastasia Velentza, Ph.D., VP and Head of Biology, Vilya Anastasia Velentza is currently VP and Head of Biology at Vilya, a biotechnology company founded on computational design of novel macrocycle drugs to address unmet medical needs and transform patients’ lives. Anastasia is also the Founder and Owner of AVeNew Insights, a Consulting Company providing service and advice across all aspects of Drug Discovery. Previously, she was the Head of Discovery Technology at Plexium, a Targeted Protein Degradation company. Anastasia has more than 20 years in Drug Discovery, with expertise in Discovery Biology and Molecular Pharmacology across multiple therapeutic areas, modalities and targets. Before Plexium, she held positions of increasing responsibility at Novartis, Dart Neuroscience and Ferring Pharmaceuticals. Anastasia was NIH Research Award scholar in a drug discovery training program at Northwestern University in Chicago, IL. She earned her Bachelor of Science in Chemistry at the Univers